Brief: Livanova Receives 510(k) Clearance For ECMO From FDA For LifeSPARC, The Next-Generation Advanced Circulatory Support System
17/11/2022 14:16
Nov 17 (Reuters) - LivaNova PLC LIVN.O :
* LIVANOVA RECEIVES 510(K) CLEARANCE FOR ECMO FROM FDA FOR
LIFESPARC, THE NEXT-GENERATION ADVANCED CIRCULATORY SUPPORT
SYSTEM
Source text for Eikon: ID:nBwbq2c9va
Further company coverage: LIVN.O
Recent news on Livanova
See all newsAIM - Schedule One Update - TEK 4 Holdco Limited
Competition and Mkts - Merger Update: NRG Fleet / Specialist Fleet
LivaNova PLC reports results for the quarter ended June 30 - Earnings Summary
UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlook
Brief: Livanova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming In OSPREY Study